Rahman Ashequr, Inoue Toshio, Ago Jun, Ishikawa Takashi, Kamei Chiaki
Department of Medicinal Pharmacology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Tsushima-naka 1-1-1, Okayama 700-8530, Japan.
Eur J Pharmacol. 2007 Jan 12;554(2-3):229-34. doi: 10.1016/j.ejphar.2006.09.060. Epub 2006 Oct 10.
This study was undertaken to investigate the interactive effect of histamine and prostaglandin D(2) in nasal allergic symptoms in rats. The intranasal application of histamine at doses lower than 10 mumol/site caused no sneezing or nasal rubbing. In addition, prostaglandin D(2) also showed no significant increase in these responses, even at a dose of 10 nmol/site. On the other hand, the simultaneous instillation of histamine and prostaglandin D(2) resulted in a 1000 times more potent effect in inducing nasal symptoms than the administration of histamine alone. Thus, prostaglandin D(2) enhanced the actions of histamine in inducing sneezing and nasal rubbing in a dose-dependent manner, and significant effects were observed at doses higher than 1 nmol/site. The responses induced by the simultaneous application of histamine and prostaglandin D(2) were inhibited by chlorpheniramine, cyproheptadine, BW A868C and ramatroban. Chlorpheniramine and cyproheptadine showed the dose-related inhibition of nasal symptoms induced by the combined administration of histamine (10 nmol) and prostaglandin D(2) (10 nmol), but the effect of cyproheptadine was relatively weak compared with chlorpheniramine. Moreover, BW A868C and ramatroban also showed the inhibition of nasal symptoms induced by the simultaneous administration of histamine and prostaglandin D(2) in a dose-dependent manner. BW A868C was more potent in inhibiting the nasal symptoms than ramatroban. These results clearly indicate that prostaglandin D(2) showed a synergistic effect on sneezing and nasal rubbing induced by histamine in rats, and its effect occurred through both prostaglandin D(2) and CRTH2 (chemoattractant receptor-homologous molecule expressed on TH2 cells) receptors.
本研究旨在探讨组胺与前列腺素D2在大鼠鼻部过敏症状中的相互作用。鼻内给予低于10 μmol/部位剂量的组胺未引起打喷嚏或鼻擦行为。此外,即使给予10 nmol/部位剂量的前列腺素D2,这些反应也未显著增加。另一方面,同时滴注组胺和前列腺素D2诱导鼻部症状的效力比单独给予组胺强1000倍。因此,前列腺素D2以剂量依赖方式增强组胺诱导打喷嚏和鼻擦行为的作用,且在高于1 nmol/部位剂量时观察到显著效果。同时给予组胺和前列腺素D2所诱导的反应可被氯苯那敏、赛庚啶、BW A868C和雷马曲班抑制。氯苯那敏和赛庚啶对组胺(10 nmol)和前列腺素D2(10 nmol)联合给药诱导的鼻部症状呈现剂量相关的抑制作用,但与氯苯那敏相比,赛庚啶的作用相对较弱。此外,BW A868C和雷马曲班也以剂量依赖方式抑制组胺和前列腺素D2同时给药诱导的鼻部症状。BW A868C抑制鼻部症状的效力比雷马曲班更强。这些结果清楚地表明,前列腺素D2对组胺诱导的大鼠打喷嚏和鼻擦行为具有协同作用,且其作用通过前列腺素D2和CRTH2(Th2细胞上表达的趋化因子受体同源分子)受体共同介导。